These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18697860)

  • 1. Recognition and management of dyslipidemia in children and adolescents.
    Kwiterovich PO
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4200-9. PubMed ID: 18697860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory assessment of cardiovascular risk in children: Guidelines for screening, evaluation, and treatment.
    Kwiterovich PO
    J Clin Lipidol; 2008 Aug; 2(4):248-66. PubMed ID: 21291741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of dyslipidemia in children and adolescents.
    Holmes KW; Kwiterovich PO
    Curr Cardiol Rep; 2005 Nov; 7(6):445-56. PubMed ID: 16256015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and treatment of dyslipidemias in children and adolescents.
    Daniels SR
    Horm Res Paediatr; 2011; 76 Suppl 1():47-51. PubMed ID: 21778749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Morrison CC; Dunn J; Nguyen M; Blasi PR; Whitlock EP
    JAMA; 2016 Aug; 316(6):634-44. PubMed ID: 27532918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein (a): Examination of Cardiovascular Risk in a Pediatric Referral Population.
    Qayum O; Alshami N; Ibezim CF; Reid KJ; Noel-MacDonnell JR; Raghuveer G
    Pediatr Cardiol; 2018 Dec; 39(8):1540-1546. PubMed ID: 29948030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric dyslipidemia: recommendations for clinical management.
    Wilson DP; McNeal C; Blackett P
    South Med J; 2015 Jan; 108(1):7-14. PubMed ID: 25580750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and management of dyslipidemic children.
    Guardamagna O; Baracco V; Abello F; Bona G
    Minerva Pediatr; 2009 Aug; 61(4):391-8. PubMed ID: 19752848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dyslipidemia management in children and adolescents: recommendations of the Nutrition Branch of the Chilean Society of Pediatrics].
    Barja Y S; Cordero B ML; Baeza L C; Hodgson B MI;
    Rev Chil Pediatr; 2014 Jun; 85(3):367-77. PubMed ID: 25697255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of dyslipidaemia in childhood.
    Kusters DM; Vissers MN; Wiegman A; Kastelein JJ; Hutten BA
    Expert Opin Pharmacother; 2010 Apr; 11(5):739-53. PubMed ID: 20210683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of inherited atherogenic dyslipidemias in children.
    Guardamagna O; Cagliero P; Abello F
    Ther Apher Dial; 2013 Apr; 17(2):150-61. PubMed ID: 23551671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on screening, etiology, and treatment of dyslipidemia in children.
    Bamba V
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3093-102. PubMed ID: 24848708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidemia therapy update: the importance of full lipid profile assessment.
    Menown IB; Murtagh G; Maher V; Cooney MT; Graham IM; Tomkin G
    Adv Ther; 2009 Jul; 26(7):711-8. PubMed ID: 19649582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk factors and non-invasive assessment of subclinical atherosclerosis in youth.
    Morrison KM; Dyal L; Conner W; Helden E; Newkirk L; Yusuf S; Lonn E
    Atherosclerosis; 2010 Feb; 208(2):501-5. PubMed ID: 19699477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
    Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
    Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Goldstein BI; Carnethon MR; Matthews KA; McIntyre RS; Miller GE; Raghuveer G; Stoney CM; Wasiak H; McCrindle BW; ;
    Circulation; 2015 Sep; 132(10):965-86. PubMed ID: 26260736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid screening and cardiovascular health in childhood.
    Daniels SR; Greer FR;
    Pediatrics; 2008 Jul; 122(1):198-208. PubMed ID: 18596007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal versus targeted blood cholesterol screening among youth: The CARDIAC project.
    Ritchie SK; Murphy EC; Ice C; Cottrell LA; Minor V; Elliott E; Neal W
    Pediatrics; 2010 Aug; 126(2):260-5. PubMed ID: 20624798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening adolescents for lipid disorders: what is the best approach?
    Jenssen BP; Jacobson MS
    Adolesc Med State Art Rev; 2008 Dec; 19(3):507-20, x. PubMed ID: 19227389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening programme for hyperlipidemia in children and adolescents. Prophylactic aspects of atherosclerosis.
    Radomyska B
    Med Wieku Rozwoj; 2001; 5(1):27-34. PubMed ID: 11276501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.